Jane Street
NMTR

Jane Street’s 9 Meters Biopharma NMTR Stock Holding History

Jane Street’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,251
Closed -$25K – 11310
2021
Q4 		$25K Sell
1,251
-5,920
-83% -$132K ﹤0.01% 9747
2021
Q3 		$186K Sell
7,171
-12,569
-64% -$296K ﹤0.01% 8907
2021
Q2 		$434K Buy
19,740
+14,115
+251% +$347K ﹤0.01% 7507
2021
Q1 		$132K Buy
+5,625
New +$173K ﹤0.01% 8525
2019
Q3 		– Sell
-646
Closed -$15K – 5953
2019
Q2 		$15K Buy
646
+133
+26% +$3.99K ﹤0.01% 5027
2019
Q1 		$20K Buy
+513
New +$22.2K ﹤0.01% 4904
2018
Q2 		– Sell
-392
Closed -$214K – 5787
2018
Q1 		$214K Buy
+392
New +$76.3K ﹤0.01% 4394

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street's NMTR Position: Q1 2022 in Review

Jane Street sold out of 9 Meters Biopharma (NMTR) in Q1 2022, closing a stake of 1,251 shares — an estimated $25K sold.

Jane Street first reported a position in NMTR in Q1 2018 and held it in 7 quarters. The position peaked at $434K in Q2 2021. 101 funds tracked by Wall St. Rank hold NMTR as of Q1 2022.

  • Jane Street reported no remaining 9 Meters Biopharma position as of Q1 2022 after selling out during the quarter.
  • Jane Street sold 1,251 9 Meters Biopharma shares in Q1 2022, an estimated $25K.
  • Jane Street first reported a position in 9 Meters Biopharma in Q1 2018 and held it in 7 quarters.
  • Jane Street's 9 Meters Biopharma position peaked at $434K in Q2 2021.
  • 101 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q1 2022.

Based on Jane Street's 13F filing for Q1 2022, filed 17 May 2022.